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INTRODUCTION
Prescribing is an essential task for any 
doctor. It involves weighing up the benefits 
of treatments against the risk of possible 
harm. Over 900 million items are dispensed 
in the community in England each year,1 yet 
relatively little is known about the prevalence 
and underlying causes of prescribing errors 
in general practice.2 One study explored 
the causes of preventable, drug-related, 
admissions to hospital and found problems 
at multiple stages in the medication 
use process, including prescribing.3 The 
EQUIP study investigated the causes of 
prescribing errors by foundation trainees 
in secondary care and uncovered many 
factors that led to errors.4 The study team 
also conducted a major study of the causes 
of prescribing errors in an English hospital, 
and identified many risk factors including 
inadequate training and an absence of 
self-awareness of errors.5 A systematic 
review in 2009 concerning the causes of 
prescribing errors in specialist and non-
specialist hospitals also reported high 
workload and inadequate communication 
between healthcare professionals as error-
provoking conditions.6 
UK primary care has received relatively 
little attention. A national reporting and 
learning service, established to collect 
spontaneously reported accounts of 
health-related error, received very little 
data from primary care organisations.7 
In the absence of evidence, the aim of 
this study was to explore the causes of 
prescribing and monitoring errors, and 
provide key recommendations for how they 
may be overcome. This article presents the 
qualitative findings from the largest, mixed 
methods study conducted over 2 years 
in a broad range of general practices in 
England.8,9
METHOD 
Ninety-seven practices across three 
primary care trusts (PCTs; the UK primary 
healthcare organisations in place at the time 
of the study) with differing characteristics 
(inner-city London, urban and suburban, 
and/or rural) were sent a letter and 
information sheet inviting them to take part; 
30 practices replied with 20 expressing 
an interest in participating. Of these, 
five practices in each of the PCTs were 
purposively selected taking into account 
differences in demographic characteristics. 
Pharmacists reviewed a 2% random sample 
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Abstract
Background 
Few detailed studies exist of the underlying 
causes of prescribing errors in the UK.
Aim
To examine the causes of prescribing and 
monitoring errors in general practice and 
provide recommendations for how they may be 
overcome.
Design and setting
Qualitative interview and focus group study 
with purposive sampling of English general 
practices.
Method
General practice staff from 15 general 
practices across three PCTs in England 
participated in a combination of semi-
structured interviews (n = 34) and six focus 
groups (n = 46). Thematic analysis informed by 
Reason’s Accident Causation Model was used. 
Results
Seven categories of high-level error-producing 
conditions were identified: the prescriber, the 
patient, the team, the working environment, 
the task, the computer system, and the 
primary–secondary care interface. These were 
broken down to reveal various error-producing 
conditions: the prescriber’s therapeutic 
training, drug knowledge and experience, 
knowledge of the patient, perception of risk, 
and their physical and emotional health; the 
patient’s characteristics and the complexity 
of the individual clinical case; the importance 
of feeling comfortable within the practice 
team was highlighted, as well as the safety 
implications of GPs signing prescriptions 
generated by nurses when they had not 
seen the patient for themselves; the working 
environment with its extensive workload, time 
pressures, and interruptions; and computer-
related issues associated with mis-selecting 
drugs from electronic pick-lists and overriding 
alerts were all highlighted as possible 
causes of prescribing errors and were often 
interconnected.
Conclusion
Complex underlying causes of prescribing and 
monitoring errors in general practices were 
highlighted, several of which are amenable to 
intervention.
Keywords
general practice; medication safety; patient 
safety; prescribing; primary care; quality.
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of medical records in each practice to identify 
potential prescribing and monitoring errors. 
Five members of the research team then 
decided whether these fitted pre-specified 
definitions for prescribing and monitoring 
errors (Box 1).10–12 
A wide range of different types of errors 
were purposefully selected, including those 
that were considered particularly serious, 
a range of different types of potential 
prescribing and monitoring errors, 
potential errors involving problems at the 
primary–secondary care interface, and less 
serious problems, where GPs may have 
wished to debate whether or not an error 
had taken place. Letters were distributed 
to prescribers potentially responsible for 
these errors inviting them to participate in 
a face-to-face semi-structured interview. 
A range of members of general practice 
staff were also invited to attend one of 
six focus groups, the purpose of which 
was to discuss safeguards in general 
practice. The research pharmacists who 
collected data on potential medication 
errors were all given training in conducting 
these interviews. All participants received 
an information sheet and provided written 
informed consent.
Face-to-face, semi-structured interviews 
were conducted between October 2010 and 
May 2011, audiorecorded with permission 
and transcribed verbatim; field notes 
were taken for those who did not wish to 
be recorded. Any information that could 
lead to a participant being identified was 
removed at the transcription stage and an 
identification code applied (Table 1). Six 
focus groups were conducted, each with a 
mix of staff groups (Table 2). One member 
of the research team led the discussions 
while another kept note of the contributions 
made by each participant so as to assist with 
transcription. All transcribed interviews and 
focus groups were re-checked for accuracy 
by a research administrator.
Analysis took place concurrently with 
data collection, with further refinement 
of the open-ended questions in the topic 
guides to investigate areas in more 
depth. Two authors then generated the 
conceptual framework13 by which these 
data were labelled and sorted. This process 
involved identifying recurring themes and 
concepts in the interviews and focus group 
transcripts, and was informed by Reason’s 
Accident Causation Model.14 A list of main- 
and sub-themes was applied systematically 
to the whole data set with the aid of the 
computerised software QSR N-Vivo (version 
8.0). Field notes were also coded and 
analysed. Using the ‘constant comparison’ 
technique,15 the lead researcher moved 
backwards and forwards between these 
data and evolving explanations until a fit 
was clearly made. Apparent ‘negative 
cases’ were also examined to further refine 
the explanations presented. 
RESULTS
A total of 34 participants were interviewed 
about 70 errors (Table 1), with 32 agreeing 
to be audiorecorded. Forty-six individuals 
participated in the six focus groups (Table 2). 
Seven high-level categories were identified: 
the prescriber, the patient, the team, the 
work environment, the task, the computer 
system, and the primary–secondary care 
interface. Each of these categories are 
discussed below, before drawing on their 
implications.
The prescriber
Five error-producing conditions were 
found to affect the prescriber, namely 
How this fits in
There have been very few detailed 
investigations of the underlying causes of 
prescribing errors in the UK. Those studies 
which already exist have largely been 
confined to secondary care. This study 
highlighted a multitude of factors that were 
found to have contributed to prescribing 
and monitoring errors in general practice. 
The prescriber’s therapeutic training, 
drug knowledge and experience were 
all identified as possible causes, as too 
were the patient’s characteristics and 
the complexity of the individual clinical 
case. The working environment, with 
its high workload, time pressures, and 
interruptions, was also considered a 
possible cause. Several of these identified 
causes are amenable to intervention, 
including improved training, and more 
effective clinical governance, while others 
such as workload, time pressures and 
interruptions, are likely to be more difficult 
to address. 
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Box 1. Definitions of prescribing and monitoring errors
A prescribing error occurs when, as a result of a prescribing decision or prescription-writing process, 
there is an unintentional, significant reduction in the probability of treatment being timely and effective, or 
increase in the risk of harm when compared to generally accepted practice.10 
A monitoring error occurs when a prescribed medicine is not monitored in the way which would be 
considered acceptable in routine general practice. It includes the absence of tests being carried out at the 
required frequency, with tolerance of +50%. If a patient refused to give consent for a test, then this would 
not constitute an error.12
their therapeutic training, drug knowledge 
and experience, knowledge of the patient, 
perception of risk, and physical and 
emotional health. A lot of GPs’ therapeutic 
knowledge was felt to have been picked up 
on the job by talking among their hospital 
peers while in training. The importance of 
hands-on training experience with a range 
of chronic disease patients at varying stages 
of their illnesses was emphasised: 
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Table 1. Characteristics of the interview participants
Participant Length of    Clinical Number of Role  Number of 
identification audiorecording,  Medical Decade interests/ years in within Working potential errors 
labela minutes Sex school qualifiedb specialty professionc practice hours discussed
PR1-GP1 68.0 M London 1980s Prescribing advisor 15–19 GP partner F/T 4
PR1-GP2 36.0 M Leicester 2000s Men’s health, dermatology <5 GP partner F/T 1
PR2-GP1d 21.0 F Nottingham 1980s Gynaecology, depression 25–29 GP partner P/T 1
PR2-GP2 31.3 F Nottingham 2000s Women’s health and children 5–9 GP partner P/T 2
PR2-GP3d 39.4 M Nottingham 1970s Minor surgery/injections 20–24 GP partner F/T 3
PR3-GP1d 41.2 M Nottingham 1980s Psychiatry/ENT 20–24 GP partner F/T 2
PR3-GP2d 30.4 F Nottingham 1980s Gynaecology 25–29 GP partner P/T 2
PR4-GP1 46.4 M Nottingham 1990s None 10–14 GP partner P/T 2
PR4-GP2 45.5 F London 1990s Palliative care, 10–14 GP partner P/T 3 
     contraception, diabetes 
PR5-GP1 19.5 F London 1980s Women’s health and 20–24 GP partner P/T 2 
     children, sexual, mental 
PR5-GP2 29.3 M London 1980s Alcohol, mental health 20–24 Senior GP partner F/T 2
PR5-GP3 22.3 F Sheffield 1980s None volunteered 10–14 Salaried GP P/T 1
PR5-GP4 25.6 M Nottingham 1980s None volunteered 15–19 GP partner P/T 0
PR6-GP1 34.5 F Edinburgh 2000s Gynaecology, dermatology <5 GP partner P/T 3
PR6-GP2 29.4 F Sri Lanka 2000s Gynaecology 5–9 GP partner F/T 2
PR6-NU1 12.3 F Luton 1990s None recorded 10–14 Nurse prescriber F/T 1
PR6-GP4 10.1 F London 1980s Paediatrics, diabetes 10–14 GP partner F/T 1
PR7-GP1 26.6 M Newcastle 1980s Skin surgery 15–19 GP partner P/T 1
PR7-GP2 7.3 M Newcastle 1980s Sports medicine, ENT, 15–19 GP partner F/T 1 
     diabetes, orthopaedics 
PR7-GP3 27.3 M Glasgow 1970s Chronic diseases 20–24 Senior GP partner F/T 2
PR7-GP4 45.3 F Newcastle 1980s Medicines management 20–24 GP partner P/T 5
PR8-GP1 26.0 M Liverpool 1980s Gynaecology 25–29 Senior GP partner F/T 2
PR9-GP1 22.3 F Leeds 1980s Gynaecology 25–29 Senior GP partner F/T 5
PR10-GP1 19.5 M Italy 1990s Asthma, COPD, diabetes 20–24 Senior GP partner,  F/T 3 
       clinical lead
PR10-GP2 16.1 M India 1970s None volunteered 30–34 Senior GP partner F/T 1
PR11-GP1 N/A M London 1970s None volunteered 25–29 Senior GP partner F/T 1
PR11-GP2 N/A F Cambridge 1980s Women’s health and children 20–24 Senior GP partner F/T 1
PR12-GP1 10.3 M Australia  2000s None <5 GP partner F/T 1
PR12-GP2 12.5 M London 1980s None 25–29 GP partner F/T 4
PR13-GP1 13.5 M Cambridge 1970s Gastroenterology, 25–29 Senior GP partner F/T 2 
     musculoskeletal 
PR13-GP2 13.3 M Italy 1970s Paediatrics 20–24 GP partner F/T 3
PR14-GP1 14.6 M Sheffield 2000s Diabetes, dermatology <5 Salaried GP P/T 3
PR14-GP2 19.2 M Nigeria 1990s Minor surgery, CVD 5–9 Salaried GP F/T 2
PR14-GP3 6.4 F London 1980s Women’s health 20–24 Salaried GP P/T 1 
       clinical lead  
aThe participant identification code identified the practice (PR1 = practice one) and the different types of participant: GP = general practitioner; NU = nurse prescriber. 
bActual dates of qualification are not given to preserve anonymity. cActual number of years in the profession are not given to preserve anonymity. dAll four interviews were 
conducted by a GP. CVD = cardiovascular disease. COPD = chronic obstructive pulmonary disease. ENT = ear, nose and throat. F = female. F/T = full-time. M = male. N/A = 
not applicable. P/T = part-time.
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‘‘You never got any of the chronic conditions 
beyond a certain point so even if you 
diagnosed someone as diabetic you only 
had them on metformin and that would be 
it.’ (PR3-GP2)
GPs tended to develop a repertoire of 
drugs that they were comfortable prescribing 
and exercised caution when using new, 
unusual, or unfamiliar drugs. One GP felt 
that time pressures made it difficult for 
her to calculate doses based on weight for 
paediatric patients and admitted just putting 
‘as directed’ on her prescriptions. Some GPs 
admitted becoming ‘slightly blasé’ (PR1-GP1) 
about prescribing overtime, possibly running 
the risk of overlooking certain things. 
GPs appeared to perceive and manage 
risk differently, with one GP admitting being 
much more ‘laissez faire’ about things than 
his colleagues: 
‘And so there’ll be some doctors, like X, 
who’s very thorough and really spend[s] a lot 
of time on these things and there’ll be some 
doctors, like me, at the other end probably 
who are much more laissez faire about this. 
Hopefully still safe but less worried about 
medication in general’. (PR4-GP1)
Perceptions of risk appeared to be 
influenced by whether the GP was aware 
of having made an error in the past and the 
severity of potential adverse drug effects. 
Tiredness and anxiety may also have affected 
the ability of some GPs to concentrate.
The patient 
Patient characteristics and the complexity 
of the individual clinical case were found to 
have contributed to prescribing errors. GPs 
perceived some patients as difficult and 
demanding: 
‘She’s the kind of patient that knows what 
she wants and she tells you what she wants.’ 
(PR11-GP2) 
‘[Some patients] actively change their 
medication on a regular basis because they 
think know best.’ (PR1-GP1)
‘[Some patients could do a] circuit of all the 
doctors for the same thing [in order] to get 
the answer that they want.’ (PR7-GP1)
A tension was highlighted between the 
GP’s responsibility to improve or maintain 
their patient’s health and the patient’s 
responsibilities for their own health. One 
GP admitted compromising with his patient 
in order for her to agree to have regular 
lithium monitoring done. The fact that she 
had been stable on lithium for quite a long 
time and had agreed to follow instructions 
if her results were abnormal, solicited just 
enough leniency from this GP to allow her to 
have blood tests extended to every 6 months 
(rather than every 3 months). 
The team 
Poor communication and nurses’ ‘quasi-
autonomous role’ (PR3-GP1) in chronic 
disease management were considered 
to be two key conditions influencing the 
occurrence of prescribing errors. Several 
GPs’ accounts highlighted the importance 
of feeling comfortable within the practice 
team and being able to share any anxieties 
or worries that they may have. Although it 
had become customary in general practice 
for GPs to sign prescriptions generated by 
nurses, one GP questioned the safety of this 
process: 
‘[I find it] a little bit uncomfortable because 
I’m not actually seeing the patient myself 
but it’s the nature of general practice, it’s 
the way it’s happened for many years. That’s 
not to say it’s the right way but, you know, at 
Table 2. Summary of participants contributing to the six focus groups 
Focus group Length of focus Participants in     
number group, minutes each focus group, n GPs, n Nurses, n Reception staff, n Other staff, na
FG1 42 7 3 0 1 3
FG2 56 9 3 2 0 4
FG3 60 9 4 1 1 3
FG4 72 7 3 1 2 1
FG5 45 5 2 1 1 1
FG6 35 9 3 2 2 2
Total N/A 46 18 7 7 14
aThese other staff comprised: three dispensers, three prescription clerks, two practice managers, a community pharmacist, a GP registrar, a medical student, a PCT 
pharmacist, a reception manager, and a senior receptionist. N/A = not applicable. 
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the moment these particular girls [nurses] 
haven’t, can’t prescribe for themselves.’ 
(PR2-GP1)
The responsibility associated with 
signing these prescriptions appeared to 
weigh heavily on several GPs’ minds, with 
some preferring the idea of independent 
nurse prescribers who signed their own 
prescriptions. 
The working environment
GPs and practice staff reported regular 
periods of high workload and time pressures:
‘If I’m running an hour late, (…) the first lady 
[seen in the surgery] didn’t get much of a 
clinical entry or got a very badly typed one.’ 
(PR3-GP1) 
‘The critical use of time is for me the biggest 
single stress factor in general practice. The 
fact that there’s so much to do in such a 
short space of time, that you are almost 
inevitably going to make some mistake.’ 
(PR2-GP2) 
Two important conditions were felt to 
contribute to this inherently stressful working 
environment: the appointment system and 
patient demand. One GP recounted how 
they had an obligation to offer patients an 
appointment within a specified period of time, 
but questioned this necessity when patients 
often turn up with only routine issues. 
The potential for GPs to be distracted and 
interrupted was felt to be enormously high:
‘[Distractions] knock us out of our stride 
[and things] go wrong because you’re not 
in that closed zone and giving it your entire 
attention.’ (PR3-GP1)
Several doctors described how difficult 
it was when nurses ‘put their head round 
the corner’ (PR2–GP1) and ask them to sign 
prescriptions (as described above). It was felt 
that such interruptions could lead to errors if 
they did not take sufficient time to stop and 
look at what the nurse had prescribed. For 
others, their most pressing concern was 
how they may lose track of what they had 
been entering before they got interrupted:
‘You get interrupted in-between times, the 
minute somebody sees your door open they 
pounce, or sees a patient leave they pounce 
and you’re filling in the notes and suddenly 
somebody’s pounced, then that distracts 
you from completing the notes properly 
or completing the task properly because 
you don’t write all the notes in with the 
patient. And then you’re running late so you, 
I suppose cut corners would be a way of 
describing it, you try, and then that’s when it 
goes wrong.’ (PR3-GP1)
Some GPs also described how difficult 
it was to maintain concentration when the 
patient was ‘sort of nattering in your ear’ 
(PR7-GP1) or ‘comes and presents you with 
a whole battery of symptomology’ (PR3-GP1): 
‘This lady brings an awful lot to the table. And 
she persistently overruns her consultation. 
(…) And it’s often the “while I’m here” 
scenario, “oh by the way” or you get so 
cluttered up in your 10 minute task with 
other things (…) all the time, she gives you 
that feeling “Oh God, she’s back again!” and 
so what happens is you get distracted and 
you don’t complete the task because you’re 
just relieved and you’re 20 minutes late, and 
you just quickly sort things out.’ (PR3-GP1)
The task
This study concentrates on two main 
medication-related tasks in general 
practice: repeat prescribing and patient 
monitoring. Risks were presented in the 
ordering, processing, and signing stages of 
repeat prescribing. One practice stopped 
receiving requests on the phone because 
of the potential for medication errors. 
Concerns were also raised around patients 
ticking the wrong box on SystmOne (GP 
clinical system) when you have two drugs 
with similar names next to one another. One 
GP recalled how a few significant events 
had occurred in the processing stage, with 
multiple prescriptions getting mixed up or 
separated for the same patient. Another GP 
explained how sometimes short courses can 
become long ones when he is not giving the 
task his full attention:
‘Inattention creeps in (…) you give them, you 
know, 2 weeks, 3 weeks whatever of ibu 
[ibuprofen] or another NSAID [non steroidal 
anti-inflammatory drug], and then they 
come back (…) to the desk, “Can so-and-so 
have an extra repeat?” or “They’ve just run 
out of this”, “Can they have that?”, it goes on. 
That then somehow ends up in perpetuity 
because it can get put on repeat.’ (PR3-GP1)
Patient monitoring was influenced by a 
number of conditions including the practice 
system and the patient, the communication 
between healthcare settings, and the 
prescriber. One GP admitted that their 
practice was slightly more on the ‘ad hoc 
side’, relying on the patient to turn up for 
monitoring.
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‘We could probably sit down here and think 
which drugs do we want to actively monitor 
and we could just run a search on them 
every month (…) And it wouldn’t be a huge job 
but we’ve never got round to it. So we rely on 
patients.’ (FG2–GP2)
Patients on warfarin were felt to be 
especially hard to keep track of, with one 
GP explaining how the ‘system really should 
be flagged up as a whole area [of] risk’ 
(FG4–GP2).
‘You can be issuing warfarin and have no idea 
what the patient’s INR is and no idea whether 
they’re turning up anywhere, and we’re not 
automatically getting results through and 
advice that the clinics are giving’. (FG4–GP2)
The role of the prescriber within the 
practice (locum or partner) was also felt to 
impact on patient monitoring, with locums in 
particular perceived as unwilling to take the 
necessary responsibility:
‘There’s a real risk that patients get lost to 
follow-up if their regular doctor isn’t here 
all the time, like I’m not (…) there’s a range 
of social services [issues for some of them] 
that (…) can be a lot of work and I dare say 
sometimes the GP in question says, “Crikey, 
stay well clear out of this one” sort of thing.’ 
(PR6-GP2). 
The computer system 
Computer-related issues associated 
with selecting the wrong item from an 
electronic pick-list and unnecessary and/
or inappropriate alerts were highlighted as 
possible error producing conditions:
‘If you have too many warnings from 
the computer then that makes you tend 
to override them, you become a bit more 
cavalier and that’s a danger.’ (PR6-NU1)
Certain drugs, like insulin, were 
considered to be particularly difficult to pick 
from electronic lists:
‘You’ve got to find the right word to start with 
[when picking insulin] or you don’t get the 
right pick list.’ (FG4 – Nurse 1). 
The speed with which the computer 
operated may have also contributed to these 
picking errors: 
‘Our problem here is our computers are 
rubbish. They work really, really slowly (…) 
it takes a long time to come through so we 
scroll down an option, a pick list, it can pick 
the wrong thing which is very frustrating.’ 
(PR3-GP2)
‘[I’m] surprised how many times it says 3 out 
of 3 [strong alert] and yet the doctors don’t 
actually look at it.’ (PR6-GP2). 
The primary–secondary care interface 
Problems with the timeliness, legibility, 
content, and layout of secondary care 
correspondence were all felt to increase 
the risk of prescribing errors. Patients often 
visited their GPs before this correspondence 
was received, which resulted in them trying 
to piece together what changes in patient 
management had been made with little or 
no information. The ambiguous wording of 
hospital letters was also highlighted, with 
one GP explaining how, on the top of the 
letter, it stated that there was no change to 
medication, yet, within the text of the letter, 
the hospital clinician was ‘sort of suggesting’ 
that a lower dose of risperidone should be 
prescribed. Although several GPs recognised 
the need to update patients’ computer 
records promptly with the information (once 
received), they also acknowledged how some 
may ‘fall through the net’ (FG4-GP2). 
DISCUSSION
Summary
The study identified a multitude of error-
producing conditions classified into seven 
high-level categories (the prescriber, the 
patient, the team, the work environment, the 
task, the computer system, and the primary–
secondary care interface) that contributed 
to prescribing and monitoring errors. 
Categories equivalent to those in Reason’s 
model were identified,14 with an additional 
two (the computer system and the primary–
secondary care interface) considered relevant 
for the English general practice setting.
Strengths and the limitations
The sampling strategy allowed the study to 
cover a range of different locations (inner-
city, urban, suburban and rural) and practices 
(GP training and dispensing). It is possible, 
however, that the recruited practices had 
relatively high levels of interest in prescribing 
and a greater openness to external scrutiny of 
potential prescribing errors. All interviewees 
spoke openly (and often candidly) about their 
experiences and the difficulties they faced. 
It is noted that the study practices had a 
higher than average deprivation score,8 which 
may have affected the generalisability of the 
findings. Finally, it is recognised that these 
data represent the accounts of the healthcare 
professionals interviewed, and may not 
necessarily accord with their behaviour. 
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Comparison with existing literature
Other studies in the hospital setting have 
reported similar error-producing conditions, 
such as a lack of training or experience.4–6 
Some GPs struggled with the management of 
patients with complex, long-term conditions 
in this study, having only limited exposure 
to the varying stages of complex illnesses 
in training; this need should be addressed. 
A second important finding related to GPs’ 
perception of risk. Grol suggested that 
different cultures and forms of medical 
education may lead to differences in GPs’ 
attitudes to risk-taking between countries.16 
Some GPs also acknowledged becoming 
slightly blasé about the treatment of patients 
who they had known for a long time. There 
may be benefits to using an independent 
health professional (such as a sessional 
practice pharmacist) to review these 
patients’ repeat medications at appropriate 
intervals.17 Some patients were perceived 
as difficult and demanding; it is possible that 
they intentionally and consciously express 
themselves in a particular way to evoke a 
specific response from their GP.18,19 While 
patients’ choices are important,20 some GPs 
may need help developing strategies to resist 
patient pressure to prescribe where the risks 
of harm are particularly high. Communication 
within and between practice colleagues and 
healthcare settings also appeared to influence 
the occurrence of prescribing errors.21 
Interruptions went hand-in-hand with the 
process of signing nurse prescriptions in 
some practices, thus reinforcing the need for 
nurses to issue prescriptions based on their 
own clinical assessment and judgement as 
non-medical prescribers, in line with current 
UK legislation.22
High workload and time pressures were 
also perceived to contribute to errors. The 
importance of time as a key component 
of the social organisation of health has 
previously been examined.23 GP workload 
levels need to be reviewed and adjusted to 
allow sufficient time for safe prescribing and 
medicines management. One option may 
be to increase the size of the GP workforce, 
while another may be to train more non-
medical prescribers, particularly sessional 
practice pharmacists, to deal with patients 
with complex medication regimes.24 The 
computer-related issues uncovered in this 
study have previously been highlighted in 
the literature.25–27 General practices need to 
make the best use of the existing features of 
their clinical computer systems. A number 
of recommendations arose from this mixed-
methods study;9 these are summarised 
in Box 2. Further research has also been 
funded to look at specific tools to assess 
different aspects of patient safety and how 
these errors can be reduced.28
Implications for research and practice
This study highlighted the complex underlying 
causes of prescribing and monitoring errors 
in general practices. Several of these are 
amenable to intervention, including improved 
training and safer systems for medication 
review and monitoring, while others are 
likely to be more difficult to address, such as 
workload and time pressures. Nevertheless, 
by tackling the range of issues identified 
in this study, it is possible that substantial 
improvements could be made to the safety 
of prescribing in general practices. 
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Box 2. Summary of key recommendations
GP training
• Additional educational support for newly qualified GPs to help them make the transition to providing  
 ongoing medicines management for patients with complex long-term conditions.
Continuing professional development for GPs
• Development of strategies to support GPs in dealing appropriately with high-risk prescribing scenarios  
 (balancing risks, benefits, patient requests, and the need to avoid error).
Clinical governance
• Conducting significant event audits.
• Reporting adverse prescribing events (and near misses) through the National Reporting and Learning  
 System.
Effective use of clinical computer systems
• The training of GPs and practice staff so that they are able to make best use of prescribing safety  
 features.
• More accurate and appropriate alerts to hazardous prescribing and to the need for blood test monitoring  
 for certain drugs.
Improving safety systems
• General practices review the procedures they have in place for minimising interruptions to clinical staff,  
 medication monitoring, and communication at interfaces in health care, to help ensure that these are as  
 safe as possible in the context of high workload and multiple competing demands on staff.
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